News Focus
News Focus
icon url

BonelessCat

10/10/14 3:05 AM

#73153 RE: farrell90 #73152

I agree. I see something more like Roche or AstraZeneca who are actively buying biopharma technology and investing in R&D.

I do not believe Cubist is large enough.

Cubist may be more likely to be Brilacidin's victim than partner.

icon url

Minotaur

10/10/14 5:21 AM

#73154 RE: farrell90 #73152

Farrel, i believe as you do that Cubist will become the victim here. If the B Results are as good as everyone expects , it could force them to make a ridiculous offer for the whole b platform. we will see.
GLTA
icon url

alwaysdreaming

10/10/14 9:16 AM

#73166 RE: farrell90 #73152

My 2 cents is that Leo has been talking to Big Pharma, but that no deal will be made till after B's results. So I'm thinking by the end of October B's data is revealed to the company and by the end of November/Thanksgiving, an agreement has been etched out.

Then it's Christmas in Steamboat Springs Colorado!